Parkside Financial Bank & Trust’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-69
| Closed | -$1.96K | – | 2114 |
|
|
2023
Q1 | $1.96K | Hold |
69
| – | – | ﹤0.01% | 1706 |
|
|
2022
Q4 | $2.02K | Hold |
69
| – | – | ﹤0.01% | 1682 |
|
|
2022
Q3 | $2K | Sell |
69
-12
| -15% | -$348 | ﹤0.01% | 1615 |
|
|
2022
Q2 | $4K | Buy |
81
+51
| +170% | +$2.52K | ﹤0.01% | 1388 |
|
|
2022
Q1 | $1K | Sell |
30
-33
| -52% | -$1.1K | ﹤0.01% | 1804 |
|
|
2021
Q4 | $3K | Hold |
63
| – | – | ﹤0.01% | 1547 |
|
|
2021
Q3 | $4K | Buy |
63
+60
| +2,000% | +$3.81K | ﹤0.01% | 1383 |
|
|
2021
Q2 | $0 | Sell |
3
-43
| -93% | – | ﹤0.01% | 1826 |
|
|
2021
Q1 | $2K | Hold |
46
| – | – | ﹤0.01% | 1547 |
|
|
2020
Q4 | $2K | Buy |
46
+23
| +100% | +$1K | ﹤0.01% | 1469 |
|
|
2020
Q3 | $1K | Buy |
+23
| New | +$1K | ﹤0.01% | 1459 |
|
|
2020
Q2 | – | Sell |
-9
| Closed | – | – | 1733 |
|
|
2020
Q1 | $0 | Sell |
9
-4
| -31% | – | ﹤0.01% | 1695 |
|
|
2019
Q4 | $1K | Hold |
13
| – | – | ﹤0.01% | 1512 |
|
|
2019
Q3 | $1K | Hold |
13
| – | – | ﹤0.01% | 1487 |
|
|
2019
Q2 | $1K | Hold |
13
| – | – | ﹤0.01% | 1501 |
|
|
2019
Q1 | $1K | Buy |
13
+1
| +8% | +$77 | ﹤0.01% | 1460 |
|
|
2018
Q4 | $0 | Buy |
12
+4
| +50% | – | ﹤0.01% | 1602 |
|
|
2018
Q3 | $1K | Hold |
8
| – | – | ﹤0.01% | 1414 |
|
|
2018
Q2 | $1K | Buy |
8
+3
| +60% | +$375 | ﹤0.01% | 1410 |
|
|
2018
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 1562 |
|
|
2017
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 1522 |
|
|
2017
Q3 | $0 | Buy |
5
+1
| +25% | – | ﹤0.01% | 1562 |
|
|
2017
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 1573 |
|
|
2017
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 1543 |
|
|
2016
Q4 | $0 | Buy |
+4
| New | – | ﹤0.01% | 1514 |
|